Rare Inflammatory Disease Treatment Market Forecast with Potential Impact, Trends, Despite COVID-19 Pandemic, Finds FMI 2022-2028



Rare Inflammatory Disease Treatment Market Size (2022)

US$ 13,249.2 Mn

Projected Market Value (2028)

US$ 17,335.8 Mn

Global Market Growth Rate (2022-2028)

4.6% CAGR

Region With Dominant Market Share

North America

With mounting instances of genetic diseases, demand for therapeutic measures have witnessed a hike, as no effective procedures exist that provide effective treatment of genetic or rare inflammatory diseases.  Chromosomal changes primarily influence prevalence of these diseases. In a bid to curtail the disease prevalence, several pharmaceutical industries have been taking efforts to make advancements in relevant drugs as well as therapeutic methods. For example, new treatment options are being developed by researchers for geriatric and pediatric patients suffering from Still’s disease, which is a rare disease linked with the inflammation of joints.

Click on the link to get Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-6428

Doctors are stepping up their efforts by creating awareness among the patients with regard to benefits of anti-inflammatory drugs, which have been deemed effective in the prevention and control of rare inflammatory diseases. Currently, there is rapid increase in the demand for authorized effective treatments of the rare inflammatory diseases.

The OOPD (Office of Orphan Products Development) has been offering incentives to drug companies, supporting the development of treatment methods for these diseases. National Institutes of Health (NIH) are providing immense support for improving patients’ health, by focusing mainly on the development of new treatment methods. Collaborative projects are being initiated by NIH in order to examine the common causes and effects of related diseases.

Significant findings from report show that the global market for rare inflammatory disease treatment will increase at an assessed 4.4% CAGR during the forecast period, 2017-2026. The report also anticipates that by 2026-end, rare inflammatory disease treatment worth nearly US$ 15,960.8Mn will be witnessed across the globe.

Increasing Inflammatory & Autoimmune Diseases to Create Opportunities for New Therapies

Several group of scientists have associated cytokine IL-23 with treatment of inflammatory and autoimmune diseases, which in turn is creating new ways of development for therapies. Researchers have identified a fundamental molecular mechanism essential to inflammatory and autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and psoriasis. The action of pro-inflammatory cytokine IL-23, depends on the organizational stimulation of its receptor, namely IL-23R.

Moreover, the occurrence of inflammatory and autoimmune diseases is increasing on a rapid pace. Globally, an approximate number of 125 million populace are affected by psoriasis and around 100 million by rheumatoid arthritis annually. The presence of inflammatory bowel infections such as ulcerative colitis and Crohn’s disease is increasing at an alarming rate in formerly unaffected fragments of the world.

Key Takeaways from Rare Inflammatory Disease Treatment Market Report for Estimated Period, 2013-2028

  • In terms of revenue, North America will remain the largest market for rare inflammatory disease treatment market, closely followed by Europe. Nearly half value share of the market is held by rare inflammatory disease treatment sales in North America and Europe collectively. APEJ will also bolt onto a largest market revenue share, by registering a relatively faster expansion than Europe in the market through 2028.
  • On the basis of indication, ulcerative colitis are likely to remain considerably larger than that of the other segments.
  • The lion’s share in the global market for rare inflammatory disease treatment is contributed by biologics segment.
  • Oral care & Hospital Pharmacies will observe fastest growth during the forecast period.

Key market players outlined by the report is inclusive of Pfizer, Inc., Allergan Plc, Valeant, Johnson & Johnson, Questcor Pharmaceuticals, Inc., Novartis AG, Abbvie, Abbott Laboratories, Regeneron Pharmaceuticals, and Swedish Orphan Biovitrum AB.

Click on link to get TOC of this Report: https://www.futuremarketinsights.com/reports/rare-inflammatory-disease-treatment-market/table-of-content

About the Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:                                                     
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
​United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Comments

Post a Comment

Popular posts from this blog

Dairy Flavored Milk Market: Worldwide Industry Analysis of Key Findings, and New Market Opportunities Explored by 2022-2032

  Dairy Flavored milk  is a product manufactured by mixing milk, sugar or sweetener, coloring, and natural or artificial flavor. Flavored milk offers some essential nutrients like calcium, potassium, vitamins, phosphorus, and protein. Flavored milk is among the healthiest products from the food and beverage industry. Its health benefit is a boost for the market as consumers are moving towards healthy lifestyles. Also, the high shelf life and increase in demand for refrigerated milk products fuel the growth of the flavored milk market globally. The worldwide flavored milk market is supposed to arrive at a valuation of US$ 3,300 Million of every 2022. Generally speaking, deals of flavored milk are projected to develop at a strong CAGR of 6.4% somewhere in the range of 2022 and 2032, adding up to around US$ 6,119.3 Million toward the finish of 2032 The global dairy flavored milk industry is still on the rise as consumption is still low compared to other drinks like carbonated soft dri
Read more

Peanut Butter Market 2022: Increasing Demand for Efficient Management Practices, Key Segment & Opportunities Report-2030

Peanut butter is a low-calorie product with high protein content prepared from grinding of dry roasted peanuts. It serves as a substitute for the dairy butter. Peanut butter can be used as toppings for food products like bread, crackers, and many others. Peanut butter finds application in several end-user sectors such as bakery, savory and sauces, smoothies, and many more. Peanut butter is a rich source of energy that can be used as an alternative to milk butter. Aside the energy derived from the consumption, peanut butter is also a good source of protein, fiber, unsaturated fat and minerals such as magnesium, zinc, potassium, and vitamin E. With these nutritional value obtained from the consumption of peanut butter, the global market is slated to witness robust growth over the forecast period. Moreover, the growing population size of consumers with weight diseases and increasing disposable income of consumers in developed and developing countries are major factors expected to p
Read more

Global Vegan Fast Food Market Current and Future Trends, Growth Insights, Industry Segments and Regional Forecast by 2033

 The global vegan fast food market is predicted to be worth US$ 18829.5 million in 2023 and US$ 27980.2 million by 2033 The global vegan fast food market is predicted to develop due to increased knowledge about the benefits of a vegan diet. An additional factor, such as growing awareness of animal health and cruelty in the food industry, has encouraged individuals to transition from animal-based to plant-based fast food, which has contributed to the market's growth. As a result of these reasons, demand for vegan fast food is expected to rise at a constant 4.5% CAGR, with the United Kingdom, the United States, Germany, and Japan emerging as important manufacturers. Download Comprehensive Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16198 The rise in awareness of health issues and human well-being, as well as changes in lifestyle, are the factors driving the growth of the global vegan fast food market. People are migrating toward vegetarian food
Read more